Carmat, a manufacturer of artificial hearts, announced that it had successfully raised $7.4 million ($7.4 million) in cash from several of its longtime financial backers. Carmat's financial status has been under pressure. Carmat, a company owned by European aircraft manufacturer Airbus, estimated it would still need to seek an additional €50 million ($52.6 million) in funding to cover its operations and investments through the end of October 2024.

Airbus was not listed as a shareholder taking part in the capital offering, and as a result, its ownership has decreased from 11.7% to 10.8%, making it the second-largest investor after its previous first place. The second half of 2023 should bring in between $4 million and $6 million in revenue, according to Carmat, with a subsequent dramatic increase in sales in 2024.

"We are confident in the robustness and safety of our artificial heart, and in its strong potential, and are determined to lead Carmat to commercial success and profitability, with the support of our teams, shareholders and partners, for the benefit of patients suffering from advanced biventricular heart failure", Stephane Piat, CEO of Carmat, said. After one of Carmat's Founders, the late businessman Jean-Luc Lagardere, redirected engineers with expertise in precise missile parts into a new company with renowned heart surgeon Alain Carpentier in 1993, Airbus had grown to be the company's largest shareholder.